Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 318

1.

Assessing mobile health feasibility and acceptability among HIV-infected cocaine users and their healthcare providers: guidance for implementing an intervention.

Brown SE, Krishnan A, Ranjit YS, Marcus R, Altice FL.

Mhealth. 2020 Jan 5;6:4. doi: 10.21037/mhealth.2019.09.12. eCollection 2020.

2.

Safety of oral naltrexone in HIV-positive men who have sex with men and transgender women with alcohol use disorder and initiating antiretroviral therapy.

Gonzales P, Grieco A, White E, Ding R, Ignacio RB, Pinto-Santini D, Lama JR, Altice FL, Duerr A.

PLoS One. 2020 Mar 5;15(3):e0228433. doi: 10.1371/journal.pone.0228433. eCollection 2020.

3.

Online HIV information seeking and pre-exposure prophylaxis awareness among people who use drugs.

Ranjit YS, Shrestha R, Copenhaver M, Altice FL.

J Subst Abuse Treat. 2020 Apr;111:16-22. doi: 10.1016/j.jsat.2019.12.010. Epub 2019 Dec 28.

PMID:
32087834
4.

Modeling Combination HCV Treatment and Prevention Strategies in a Network of People Who Inject Drugs in the USA.

Zelenev A, Li J, Shea P, Hecht R, Altice FL.

Clin Infect Dis. 2020 Feb 15. pii: ciaa142. doi: 10.1093/cid/ciaa142. [Epub ahead of print]

PMID:
32060534
5.

Feasibility and Acceptability of an mHealth-Based Approach as an HIV Prevention Strategy Among People Who Use Drugs on Pre-Exposure Prophylaxis.

Shrestha R, Altice FL, DiDomizio E, Sibilio B, Ranjit YS, Copenhaver MM.

Patient Prefer Adherence. 2020 Jan 16;14:107-118. doi: 10.2147/PPA.S236794. eCollection 2020.

6.

Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: a modelling study.

Tan J, Altice FL, Madden LM, Zelenev A.

Lancet HIV. 2020 Feb;7(2):e121-e128. doi: 10.1016/S2352-3018(19)30373-X. Epub 2019 Dec 23.

PMID:
31879250
7.

Global patterns of opioid use and dependence: harms to populations, interventions, and future action.

Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL, Bruneau J, Altice FL, Henderson G, Rahimi-Movaghar A, Larney S.

Lancet. 2019 Oct 26;394(10208):1560-1579. doi: 10.1016/S0140-6736(19)32229-9. Epub 2019 Oct 23.

PMID:
31657732
8.

Cost-effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysis.

Morozova O, Crawford FW, Cohen T, Paltiel AD, Altice FL.

Addiction. 2020 Mar;115(3):437-450. doi: 10.1111/add.14797. Epub 2019 Oct 29.

PMID:
31478285
9.

Use of Smartphone to Seek Sexual Health Information Online Among Malaysian Men Who Have Sex with Men (MSM): Implications for mHealth Intervention to Increase HIV Testing and Reduce HIV Risks.

Shrestha R, Lim SH, Altice FL, Copenhaver M, Wickersham JA, Saifi R, Ab Halim MA, Naning H, Kamarulzaman A.

J Community Health. 2020 Feb;45(1):10-19. doi: 10.1007/s10900-019-00713-x.

PMID:
31375976
10.

Treating opioid dependence with extended-release naltrexone (XR-NTX) in Ukraine: Feasibility and three-month outcomes.

Makarenko I, Pykalo I, Springer SA, Mazhnaya A, Marcus R, Filippovich S, Dvoriak S, Altice FL.

J Subst Abuse Treat. 2019 Sep;104:34-41. doi: 10.1016/j.jsat.2019.05.008. Epub 2019 May 10.

PMID:
31370983
11.

Prisons: ignore them at our peril.

Kamarulzaman A, Verster A, Altice FL.

Curr Opin HIV AIDS. 2019 Sep;14(5):415-422. doi: 10.1097/COH.0000000000000572.

PMID:
31343458
12.

Retention in clinical trials after prison release: results from a clinical trial with incarcerated men with HIV and opioid dependence in Malaysia.

Chandra DK, Bazazi AR, Nahaboo Solim MA, Kamarulzaman A, Altice FL, Culbert GJ.

HIV Res Clin Pract. 2019 Feb;20(1):12-23. doi: 10.1080/15284336.2019.1603433. Epub 2019 May 1.

PMID:
31303149
13.

Dual motivational model of pre-exposure prophylaxis use intention: model testing among men who have sex men in Ukraine.

Ranjit YS, Dubov A, Polonsky M, Fraenkel L, Rich KM, Ogunbajo A, Altice FL.

AIDS Care. 2020 Feb;32(2):261-266. doi: 10.1080/09540121.2019.1640845. Epub 2019 Jul 9.

PMID:
31288547
14.

Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study.

Shrestha R, Altice FL, Sibilio B, Ssenyonjo J, Copenhaver MM.

Contemp Clin Trials. 2019 Jul;82:77-84. doi: 10.1016/j.cct.2019.06.012. Epub 2019 Jun 20.

PMID:
31229618
15.

HIV, Drug Injection, and Harm Reduction Trends in Eastern Europe and Central Asia: Implications for International and Domestic Policy.

LaMonaca K, Dumchev K, Dvoriak S, Azbel L, Morozova O, Altice FL.

Curr Psychiatry Rep. 2019 Jun 3;21(7):47. doi: 10.1007/s11920-019-1038-8. Review.

PMID:
31161306
16.

Staying hepatitis C negative: A systematic review and meta-analysis of cure and reinfection in people who inject drugs.

Latham NH, Doyle JS, Palmer AY, Vanhommerig JW, Agius P, Goutzamanis S, Li Z, Pedrana A, Gottfredsson M, Bouscaillou J, Luhmann N, Mazhnaya A, Altice FL, Saeed S, Klein M, Falade-Nwulia OO, Aspinall E, Hutchinson S, Hellard ME, Sacks-Davis R.

Liver Int. 2019 Dec;39(12):2244-2260. doi: 10.1111/liv.14152. Epub 2019 Jun 10.

PMID:
31125496
17.

Estimated Impact of Targeted Pre-Exposure Prophylaxis: Strategies for Men Who Have Sex with Men in the United States.

Elion RA, Kabiri M, Mayer KH, Wohl DA, Cohen J, Beaubrun AC, Altice FL.

Int J Environ Res Public Health. 2019 May 7;16(9). pii: E1592. doi: 10.3390/ijerph16091592.

18.

Impact of Abstinence and of Reducing Illicit Drug Use Without Abstinence on Human Immunodeficiency Virus Viral Load.

Nance RM, Trejo MEP, Whitney BM, Delaney JAC, Altice FL, Beckwith CG, Chander G, Chandler R, Christopoulous K, Cunningham C, Cunningham WE, Del Rio C, Donovan D, Eron JJ, Fredericksen RJ, Kahana S, Kitahata MM, Kronmal R, Kuo I, Kurth A, Mathews WC, Mayer KH, Moore RD, Mugavero MJ, Ouellet LJ, Quan VM, Saag MS, Simoni JM, Springer S, Strand L, Taxman F, Young JD, Crane HM.

Clin Infect Dis. 2020 Feb 14;70(5):867-874. doi: 10.1093/cid/ciz299.

PMID:
30994900
19.

Using nominal group technique to identify barriers, facilitators, and preferences among patients seeking treatment for opioid use disorder: A needs assessment for decision making support.

Muthulingam D, Bia J, Madden LM, Farnum SO, Barry DT, Altice FL.

J Subst Abuse Treat. 2019 May;100:18-28. doi: 10.1016/j.jsat.2019.01.019. Epub 2019 Jan 26.

PMID:
30898324
20.

Factors Associated with HIV Viral Suppression Among Transgender Women in Lima, Peru.

Rich KM, Wickersham JA, Valencia HuamanĂ­ J, Kiani SN, Cabello R, Elish P, Florez Arce J, Pizzicato LN, Soria J, Sanchez J, Altice FL.

LGBT Health. 2018 Nov/Dec;5(8):477-483. doi: 10.1089/lgbt.2017.0186.

Supplemental Content

Loading ...
Support Center